HomeCPIX • NASDAQ
Cumberland Pharmaceuticals, Inc.
add
$4.23
1.63%
After Hours:(5.44%)-0.23
$4.00
Closed: Apr 4, 7:43:03 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 10.44M | 11.57% |
Operating expense | 10.30M | -3.35% |
Net income | -1.90M | 69.75% |
Net profit margin | -18.24 | 72.90% |
Earnings per share | — | — |
EBITDA | -345.65K | 78.43% |
Effective tax rate | 2.91% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 17.96M | -1.95% |
Total assets | 75.58M | -7.57% |
Total liabilities | 53.04M | 0.99% |
Total equity | 22.55M | — |
Shares outstanding | 13.97M | — |
Price to book | 2.62 | — |
Return on assets | -6.05% | — |
Return on capital | -10.34% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -1.90M | 69.75% |
Cash from operations | 1.90M | 83.12% |
Cash from investing | -26.81K | -110.29% |
Cash from financing | -1.38M | 7.31% |
Net change in cash | 499.43K | 368.02% |
Free cash flow | 1.28M | -78.62% |
Previous close
$4.30
Day range
$4.11 - $4.27
Year range
$1.05 - $7.25
Market cap
58.41M USD
Avg Volume
131.15K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1999
Headquarters
Website
Employees
91
